Clinical Trials Logo

Citation(s)

  •   Calleja-Agius J, Muttukrishna S, Pizzey AR, Jauniaux E
    Pro- and antiinflammatory cytokines in threatened miscarriages. Am J Obstet Gynecol. 2011 Jul;205(1):83.e8-16. doi: 10.1016/j.ajog.2011.02.051. Epub 2011 Feb 23.
  •   Nakagawa K, Kwak-Kim J, Ota K, Kuroda K, Hisano M, Sugiyama R, Yamaguchi K
    Immunosuppression with tacrolimus improved reproductive outcome of women with repeated implantation failure and elevated peripheral blood TH1/TH2 cell ratios. Am J Reprod Immunol.
  •   Ozkan ZS, Deveci D, Simsek M, Ilhan F, Risvanli A, Sapmaz E
    What is the impact of SOCS3, IL-35 and IL17 in immune pathogenesis of recurrent pregnancy loss? J Matern Fetal Neonatal Med. 2015 Feb;28(3):324-8. doi: 10.3109/14767058.2014.916676. Epub 2014 Ma
  •   Santos MA, Kuijk EW, Macklon NS
    The impact of ovarian stimulation for IVF on the developing embryo. Reproduction. 2010 Jan;139(1):23-34. doi: 10.1530/REP-09-0187. Review.
  •   Sugiura-Ogasawara M, Suzuki S, Ozaki Y, Katano K, Suzumori N, Kitaori T
    Frequency of recurrent spontaneous abortion and its influence on further marital relationship and illness: the Okazaki Cohort Study in Japan. J Obstet Gynaecol Res. 2013 Jan;39(1):12
  •   Wang L, Harris TE, Roth RA, Lawrence JC Jr
    PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding. J Biol Chem. 2007 Jul 6;282(27):20036-44. Epub 2007 May 17.
  •   Winger EE, Reed JL, Ji X
    First-trimester maternal cell microRNA is a superior pregnancy marker to immunological testing for predicting adverse pregnancy outcome. J Reprod Immunol. 2015 Aug;110:22-35. doi: 10.1016/j.jri.2015.03.005. Epub 2015 Apr 16.
  •   Winger EE, Reed JL
    Low circulating CD4(+) CD25(+) Foxp3(+) T regulatory cell levels predict miscarriage risk in newly pregnant women with a history of failure. Am J Reprod Immunol. 2011 Oct;66(4):320-8. doi: 10.1111/j.1600-0897.2011.00992.x. Epub 2011 Fe

Effect of Rapamycin on Pregnancy Rate of Patient With Recurrent Implantation Failure With Immunological Causes

Details for clinical trial NCT03161340